Influenza vaccines for preventing acute otitis media in infants and children (Q24187165)

title

Influenza vaccines for preventing acute otitis media in infants and children (English)

0 references

1 reference

1 reference

1

Mohd N Norhayati

Mohd N

Norhayati

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803008%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

2

Jacqueline J Ho

Jacqueline J

Ho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803008%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Mohd Y Azman

3

Mohd Y

Azman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803008%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

7 June 2020

language of work or name

1 reference

24 March 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803008%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803008%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

CD010089

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803008%20AND%20SRC:MED&resulttype=core&format=json

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Effectiveness of pandemic influenza A/H1N1 vaccine for prevention of otitis media in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Socioeconomic impact of influenza on healthy children and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Timing of the availability and administration of influenza vaccine through the vaccines for children program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Restricted use of antibiotic prophylaxis for recurrent acute otitis media in the era of penicillin non-susceptible Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Impact of the pneumococcal conjugate vaccine on otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Pneumococcal conjugate vaccines for preventing otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Importance of respiratory viruses in acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Short-course antibiotics for acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Diagnosis and management of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

The diagnosis and management of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Role of respiratory viruses in children with acute otitis media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Population-based impact of pneumococcal conjugate vaccine in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Assessing the evidence: live attenuated influenza vaccine in children younger than 2 years. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

A meta-analytic review of the risk factors for acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Antibiotics for otitis media with effusion in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Antibiotics for acute otitis media in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Detection of respiratory viruses in nasopharyngeal secretions and middle ear fluid from children with acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Influenza vaccine for preventing acute otitis media in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Influenza vaccines for preventing acute otitis media in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Exposure to environmental tobacco smoke as a risk factor for recurrent acute otitis media in children under the age of five years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

A Longitudinal Study of Respiratory Viruses and Bacteria in the Etiology of Acute Otitis Media with Effusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Oil-in-water emulsion adjuvant with influenza vaccine in young children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Penicillin-resistant Streptococcus pneumoniae in acute otitis media

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Prevention of otitis media in children with live attenuated influenza vaccine given intranasally

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

The Efficacy of Live Attenuated Influenza Vaccine Against Influenza-associated Acute Otitis Media in Children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021

Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010089.PUB2

7 January 2021